SKI Market

Indian Indices

Sensex

83,472.51 195.36
( 0.23%)

Global Indices

Nasdaq

49,521.93 48.93
(0.10%)

Dow Jones

6,857.17 3.41
(0.05%)

Hang Seng

56,467.09 -339.32
(-0.60%)

Nikkei 225

10,471.28 24.93
(0.24%)

Forex

USD-INR

90.69 0.10
(0.11%)

EUR-INR

107.54 -0.01
(-0.01%)

GBP-INR

123.68 0.19
(0.16%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

291.9817605

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

37.89

38055.63

EPS(TTM)

Face Value()

Div & Yield %

39.59

0.27

Back

Board of Balkrishna Industries recommends Third Interim dividend

Jan 29,2026

Balkrishna Industries announced that the Board of Directors of the Company at its meeting held on 28 January 2026, inter alia, have recommended the Third Interim dividend of Rs 4 per equity Share (i.e. 200%) , subject to the approval of the shareholders.

83,472.51 195.36 ( 0.23%)

49,521.93 48.93 (0.10%)

6,857.17 3.41 (0.05%)

56,467.09 -339.32 (-0.60%)

10,471.28 24.93 (0.24%)

90.69 0.10 (0.11%)

107.54 -0.01 (-0.01%)

123.68 0.19 (0.16%)

0.59 0.00 (-0.15%)